Amgen (Nasdaq: AMGN) reports Q2 adj-EPS of $1.14, 12 cents better than the analyst estimate of $1.02. Revenues ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE